Literature DB >> 27920020

Repeated failed non-invasive prenatal testing in a woman with immune thrombocytopenia and antiphospholipid syndrome: lessons learnt.

C Y Y Hui1, W C Tan1, E L Tan1, L K Tan1.   

Abstract

We present a case of a 37-year-old Chinese woman (gravida 4 para 0) with a history of immune thrombocytopenia and type IIb antiphospholipid syndrome. She was started on 100 mg of aspirin, 20 mg of prednisolone and 20 mg of subcutaneous low-molecular-weight heparin daily for her fourth pregnancy. She opted for non-invasive prenatal testing for aneuploidy screening but had failed results three times consecutively from insufficient fetal cfDNA initially or high variance in cfDNA counts on redraws. She declined invasive karyotyping. Her pregnancy was complicated by severe pre-eclampsia and fetal growth restriction at 19+6 weeks of gestation and was terminated. Subsequent fetal karyotyping revealed a normal karyotype of 46XY with no apparent abnormalities. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27920020      PMCID: PMC5174759          DOI: 10.1136/bcr-2016-216593

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

1.  The influence of low molecular weight heparin medication on plasma DNA in pregnant women.

Authors:  Sebastian Grömminger; Sanli Erkan; Ulrike Schöck; Kerstin Stangier; Joachim Bonnet; Rüdiger Schloo; Angela Schubert; Eva-Christina Prott; Ute Knoll; Markus Stumm; Christof von Kalle; Wera Hofmann
Journal:  Prenat Diagn       Date:  2015-09-04       Impact factor: 3.050

2.  Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.

Authors:  M M Gil; M S Quezada; B Bregant; M Ferraro; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2013-06-07       Impact factor: 7.299

Review 3.  Cell-free nucleic acids as potential markers for preeclampsia.

Authors:  S Hahn; C Rusterholz; I Hösli; O Lapaire
Journal:  Placenta       Date:  2011-02       Impact factor: 3.481

Review 4.  Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.

Authors:  M M Gil; M S Quezada; R Revello; R Akolekar; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2015-02-01       Impact factor: 7.299

5.  Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

Authors:  Eric Wang; Annette Batey; Craig Struble; Thomas Musci; Ken Song; Arnold Oliphant
Journal:  Prenat Diagn       Date:  2013-05-09       Impact factor: 3.050

6.  Adverse perinatal outcomes are more frequent in pregnancies with a low fetal fraction result on noninvasive prenatal testing.

Authors:  Iris Krishna; Martina Badell; Tammy L Loucks; Michael Lindsay; Amber Samuel
Journal:  Prenat Diagn       Date:  2016-02-05       Impact factor: 3.050

7.  Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study.

Authors:  Rossa W K Chiu; Ranjit Akolekar; Yama W L Zheng; Tak Y Leung; Hao Sun; K C Allen Chan; Fiona M F Lun; Attie T J I Go; Elizabeth T Lau; William W K To; Wing C Leung; Rebecca Y K Tang; Sidney K C Au-Yeung; Helena Lam; Yu Y Kung; Xiuqing Zhang; John M G van Vugt; Ryoko Minekawa; Mary H Y Tang; Jun Wang; Cees B M Oudejans; Tze K Lau; Kypros H Nicolaides; Y M Dennis Lo
Journal:  BMJ       Date:  2011-01-11

Review 8.  Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.

Authors: 
Journal:  Obstet Gynecol       Date:  2015-09       Impact factor: 7.661

9.  Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort.

Authors:  Eugene Pergament; Howard Cuckle; Bernhard Zimmermann; Milena Banjevic; Styrmir Sigurjonsson; Allison Ryan; Megan P Hall; Michael Dodd; Phil Lacroute; Melissa Stosic; Nikhil Chopra; Nathan Hunkapiller; Dennis E Prosen; Sallie McAdoo; Zachary Demko; Asim Siddiqui; Matthew Hill; Matthew Rabinowitz
Journal:  Obstet Gynecol       Date:  2014-08       Impact factor: 7.661

10.  Non-invasive prenatal chromosomal aneuploidy testing--clinical experience: 100,000 clinical samples.

Authors:  Ron M McCullough; Eyad A Almasri; Xiaojun Guan; Jennifer A Geis; Susan C Hicks; Amin R Mazloom; Cosmin Deciu; Paul Oeth; Allan T Bombard; Bill Paxton; Nilesh Dharajiya; Juan-Sebastian Saldivar
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

View more
  6 in total

1.  The impact of maternal autoimmune disease on cell-free DNA test characteristics.

Authors:  Hayley J MacKinnon; Teodora R Kolarova; Ronit Katz; Jaclynne M Hedge; Elena Vinopal; Christina M Lockwood; Raj Shree; Shani Delaney
Journal:  Am J Obstet Gynecol MFM       Date:  2021-08-18

2.  The Effect of Elevated Alanine Transaminase on Non-invasive Prenatal Screening Failures.

Authors:  Ping Chen; Longwei Qiao; Sheng Zhang; Jieyu Jin; Jun Cao; Yuqiong Zhang; Haoyu Tang; Zheng Yu; Jingye Shi; JingPing Yin; Yuting Liang; Xiao Wu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

Review 3.  Subtalar dislocation: a narrative review.

Authors:  G Lugani; M Rigoni; L Puddu; A Santandrea; F Perusi; D Mercurio; F Cont; B Magnan; F Cortese
Journal:  Musculoskelet Surg       Date:  2022-04-18

4.  Autoimmune disorders but not heparin are associated with cell-free fetal DNA test failure.

Authors:  Yohann Dabi; Sarah Guterman; Jacques C Jani; Alexandra Letourneau; Adèle Demain; Pascale Kleinfinger; Laurence Lohmann; Jean-Marc Costa; Alexandra Benachi
Journal:  J Transl Med       Date:  2018-12-03       Impact factor: 5.531

5.  Combining the use of a fetal fraction-based risk algorithm and probability of an informative redraw in noninvasive prenatal testing for fetal aneuploidy.

Authors:  Peter Benn; Kimberly Martin; Trudy McKanna; Elizabeth Valenti; Paul Billings; Zachary Demko
Journal:  J Genet Couns       Date:  2019-12-23       Impact factor: 2.537

6.  Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets.

Authors:  Huiwen Che; Tatjana Jatsenko; Lore Lannoo; Kate Stanley; Luc Dehaspe; Leen Vancoillie; Nathalie Brison; Ilse Parijs; Kris Van Den Bogaert; Koenraad Devriendt; Sabien Severi; Ellen De Langhe; Severine Vermeire; Bram Verstockt; Kristel Van Calsteren; Joris Robert Vermeesch
Journal:  NPJ Genom Med       Date:  2022-09-14       Impact factor: 6.083

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.